Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Wave Life Sciences Ltd. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
WVE
Nasdaq
2830
wavelifesciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Wave Life Sciences Ltd.
H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release
- Jul 3rd, 2025 7:18 am
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
- Jun 20th, 2025 2:01 pm
Raymond James bullish on biotech firms on favorable valuation
- Jun 11th, 2025 7:45 am
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
- May 29th, 2025 6:30 am
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
- May 28th, 2025 6:00 am
Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now?
- May 13th, 2025 6:45 am
Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations
- May 10th, 2025 6:51 am
WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ...
- May 9th, 2025 1:18 am
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
- May 8th, 2025 6:50 am
Wave Life Sciences: Q1 Earnings Snapshot
- May 8th, 2025 5:45 am
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
- May 8th, 2025 5:30 am
Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for
- May 1st, 2025 8:01 am
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
- May 1st, 2025 6:30 am
Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
- Apr 15th, 2025 4:29 am
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
- Mar 31st, 2025 7:03 am
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
- Mar 28th, 2025 7:39 am
Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531
- Mar 27th, 2025 7:05 am
Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar?
- Mar 27th, 2025 3:35 am
Wave Life Sciences Reports 'Positive' Data for Prospective Duchenne Treatment; Shares Up Pre-Bell
- Mar 26th, 2025 7:20 am
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
- Mar 26th, 2025 5:30 am
Scroll